Lenschow named 2021 Innovation Fund investigator by Pew Charitable Trusts
Dr. Lenchow’s research is focused on the chikungunya virus.
School of Medicine
Device that helps stroke patients control arm, hand movement with their minds receives FDA market authorization
The device leverages brain-computer interface (BCI) technology developed at WashU.
WashU faculty startup raises $5.1M in Series A funding
SentiAR’s first product, the CommandEP system, is an augmented reality software used in cardiac procedures.
Joining forces to tackle a public health challenge
Easing the burden of COVID-19 on a vulnerable group
Folding@home quickly pivots to fight COVID-19
Based at WashU Med, the computing project enlists computers around the world to aid in the fight against disease.
Washington University develops COVID-19 saliva test
The test could help simplify and expand the availability of COVID-19 diagnostic testing across broad populations.
School of Medicine researchers develop COVID-19 nasal vaccine
The vaccine can be given in one dose and has shown to be effective in mice.
National Academy of Inventors names Cote a senior member
He is recognized for developing technologies to improve cancer diagnosis, care.
Lilly acquires biotech startup founded by WashU Med researchers
Disarm Therapeutics was co-founded by Jeffrey Milbrandt, MD, PhD, and Aaron DiAntonio, MD, PhD, to speed the development of treatments for multiple neurodegenerative conditions.